Aim of this study was to evaluate, in a metropolitan area not already explored, the prevalence of Anderson-Fabry disease, by genetic screening, in patients with echocardiographic evidence of left ventricular hypertrophy (LVH) of unknown origin and "clinical red flags".
Importance of Echocardiography and Clinical "Red Flags" in Guiding Genetic Screening for Fabry Disease
Citro, RodolfoConceptualization
;Prota, CostantinaMembro del Collaboration Group
;Ferraioli, DonatellaMembro del Collaboration Group
;Bellino, MicheleWriting – Original Draft Preparation
;Radano, IlariaMembro del Collaboration Group
;Silverio, AngeloData Curation
;Polito, Maria VincenzaMembro del Collaboration Group
;Napoletano, RosaMembro del Collaboration Group
;Bellizzi, VincenzoMembro del Collaboration Group
;Ciccarelli, MicheleFormal Analysis
;Galasso, GennaroWriting – Review & Editing
;Vecchione, CarmineSupervision
2022-01-01
Abstract
Aim of this study was to evaluate, in a metropolitan area not already explored, the prevalence of Anderson-Fabry disease, by genetic screening, in patients with echocardiographic evidence of left ventricular hypertrophy (LVH) of unknown origin and "clinical red flags".File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
